|
C10ORF46 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.960400E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.257500E-02 |
| Normal-vs-Stage2 |
5.836100E-03 |
| Normal-vs-Stage3 |
2.55660000003655E-06 |
| Normal-vs-Stage4 |
2.23229999999353E-05 |
| Stage1-vs-Stage2 |
1.575000E-01 |
| Stage1-vs-Stage3 |
1.395480E-03 |
| Stage1-vs-Stage4 |
5.175200E-03 |
| Stage2-vs-Stage3 |
4.070000E-01 |
| Stage2-vs-Stage4 |
4.370200E-01 |
| Stage3-vs-Stage4 |
9.764400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.445400E-04 |
| Normal-vs-AfricanAmerican |
2.564600E-03 |
| Normal-vs-Asian |
2.761800E-01 |
| Caucasian-vs-AfricanAmerican |
9.030200E-01 |
| Caucasian-vs-Asian |
2.060100E-02 |
| AfricanAmerican-vs-Asian |
1.853700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.373400E-04 |
| Normal-vs-Female |
1.951950E-04 |
| Male-vs-Female |
8.282800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.008030E-01 |
| Normal-vs-Age(41-60Yrs) |
1.371990E-02 |
| Normal-vs-Age(61-80Yrs) |
4.27530000002285E-06 |
| Normal-vs-Age(81-100Yrs) |
4.91739999997076E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.814800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.639600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.159800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.615300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.564200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.239700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.718600E-01 |
| Normal-vs-Grade 2 |
1.545730E-02 |
| Normal-vs-Grade 3 |
3.67440000004216E-06 |
| Normal-vs-Grade 4 |
1.69656999999823E-05 |
| Grade 1-vs-Grade 2 |
9.532200E-02 |
| Grade 1-vs-Grade 3 |
3.198100E-03 |
| Grade 1-vs-Grade 4 |
1.957960E-03 |
| Grade 2-vs-Grade 3 |
6.216600E-03 |
| Grade 2-vs-Grade 4 |
9.396600E-03 |
| Grade 3-vs-Grade 4 |
4.332200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.882300E-03 |
| Normal-vs-ccB subtype |
1.346000E-02 |
| ccA subtype-vs-ccB subtype |
6.749000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.403110E-03 |
| Normal-vs-N1 |
9.035500E-02 |
| N0-vs-N1 |
9.377000E-01 |
|
|
